Why IPSC? Century Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
IPSC
$2.31+0.02 (+0.87%)
Pre-Market$2.32+0.01 (+0.43%)· Last close May 1
Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases.